CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function

P Schaerli, K Willimann, A B Lang, M Lipp, P Loetscher, B Moser, P Schaerli, K Willimann, A B Lang, M Lipp, P Loetscher, B Moser

Abstract

Leukocyte traffic through secondary lymphoid tissues is finely tuned by chemokines. We have studied the functional properties of a human T cell subset marked by the expression of CXC chemokine receptor 5 (CXCR5). Memory but not naive T cells from tonsils are CXCR5(+) and migrate in response to the B cell-attracting chemokine 1 (BCA-1), which is selectively expressed by reticular cells and blood vessels within B cell follicles. Tonsillar CXCR5(+) T cells do not respond to other chemokines present in secondary lymphoid tissues, including secondary lymphoid tissue chemokine (SLC), EBV-induced molecule 1 ligand chemokine (ELC), and stromal cell-derived factor 1 (SDF-1). The involvement of tonsillar CXCR5(+) T cells in humoral immune responses is suggested by their localization in the mantle and light zone germinal centers of B cell follicles and by the concomitant expression of activation and costimulatory markers, including CD69, HLA-DR, and inducible costimulator (ICOS). Peripheral blood CXCR5(+) T cells also belong to the CD4(+) memory T cell subset but, in contrast to tonsillar cells, are in a resting state and migrate weakly to chemokines. CXCR5(+) T cells are very inefficient in the production of cytokines but potently induce antibody production during coculture with B cells. These properties portray CXCR5(+) T cells as a distinct memory T cell subset with B cell helper function, designated here as follicular B helper T cells (T(FH)).

Figures

Figure 1
Figure 1
CCR7 and CD62L are downmodulated on tonsillar CXCR5+ T lymphocytes. Freshly isolated blood and tonsillar lymphocytes were triple stained with antibodies to CD4, CXCR5, and CCR7 or CD62L and analyzed by flow cytometry. Dot plots show cells gated for the expression of CD4. Quadrants were set according to the staining of control antibodies and the percentage of cells in each quadrant is indicated. Comparable results were obtained with five additional blood and tonsillar cell preparations.
Figure 2
Figure 2
Inhibition of migration to BCA-1 and CXCR5 expression during culture of tonsillar CXCR5+ T cells. Freshly isolated tonsillar CXCR5+ T cells were activated with immobilized anti-CD3 for up to 6 d and examined for in vitro migration (a); chemokine receptor expression was assessed by flow cytometry (b and c) and Northern blot analysis (d). (a) Chemotaxis in response to 1,000 nM BCA-1 (•), 100 nM SDF-1 (□), and 100 nM ELC (▿; mean number of migrated cells per 5 HPFs in triplicate wells). The data are representative of five independent experiments. (b) The percentage of cells positive for CXCR5 (•), CXCR4 (□), and CCR7 (▿), with gates set at 99% isotype-matched control antibody staining. (c) Expression of CXCR5, CXCR4, and CCR7 (shaded) in freshly isolated cells and in cells treated with anti-CD3 for 3 d. Broken lines represent the staining of isotype-matched control antibodies, and solid lines show chemokine receptor expression after overnight culture under nonstimulatory conditions. (d) Northern blot analysis of CXCR5, CXCR4, and CCR7 transcripts with total RNA from freshly isolated cells and after treatment with anti-CD3 for 3 and 6 d.
Figure 3
Figure 3
Lack of cytokine production but induction of IgG/IgA synthesis by CXCR5+ T cells. (a) CD4+CD45RO+ T cells were isolated from blood by negative selection. After polyclonal stimulation, CXCR5+ and CXCR5− CD4+ T cells were examined for intracellular production of IFN-γ, IL-2, IL-4, IL-5, IL-10, and IL-13 by three-color flow cytometry. Dot plots show cells gated for CD4. Quadrants were set according to the staining of isotype-matched control antibodies and the percentage of cells in each quadrant is indicated. Results are representative of a total of 11 experiments with memory T cell preparations from different blood and tonsil donors. (b) CXCR5+ T cells induce antibody production in tonsillar B cells. Tonsillar B cells were cultured for 10 d either alone (B) or in the presence of CXCR5+ (X5+/B) or CXCR5− T cells (X5−/B), and IgG, IgA, and IgM concentrations in the culture supernatants were determined by ELISA. A representative example out of four independent experiments is shown.
Figure 3
Figure 3
Lack of cytokine production but induction of IgG/IgA synthesis by CXCR5+ T cells. (a) CD4+CD45RO+ T cells were isolated from blood by negative selection. After polyclonal stimulation, CXCR5+ and CXCR5− CD4+ T cells were examined for intracellular production of IFN-γ, IL-2, IL-4, IL-5, IL-10, and IL-13 by three-color flow cytometry. Dot plots show cells gated for CD4. Quadrants were set according to the staining of isotype-matched control antibodies and the percentage of cells in each quadrant is indicated. Results are representative of a total of 11 experiments with memory T cell preparations from different blood and tonsil donors. (b) CXCR5+ T cells induce antibody production in tonsillar B cells. Tonsillar B cells were cultured for 10 d either alone (B) or in the presence of CXCR5+ (X5+/B) or CXCR5− T cells (X5−/B), and IgG, IgA, and IgM concentrations in the culture supernatants were determined by ELISA. A representative example out of four independent experiments is shown.
Figure 4
Figure 4
BCA-1 expression in tonsillar follicles. (a and c) Immunostaining of BCA-1 (red) in frozen tonsillar sections; inset in panel a shows control staining with isotype-matched control. (b) In situ hybridization of BCA-1 transcripts using an antisense probe (black) on paraffin sections; no staining is observed with a sense probe (inset in b). Positivity in the mantle zone is associated with reticular cells, as highlighted in the inset of c, and follicular HEVs (white arrowheads in c) but not T zone HEVs (black arrowheads in c). (d) Confocal microscopic analysis of BCA-1 (red) and CD31 (green) expression in follicular HEVs and T zone HEVs (inset in d). Immunostaining of interdigitating dendritic cells with an anti–S-100 antibody (e) and follicular dendritic cells with an anti-CD21 antibody (f) is shown to highlight the nonoverlapping localization of BCA-1–producing reticular cells. Original magnifications: (a, e, and f) ×100; (b and c) ×200; and (d) ×1,600.
Figure 5
Figure 5
Phenotypic characterization of follicular T cells. Immunostaining (red) on paraffin sections is shown for CD3 (a), CD20 (b), CD45RO (c), and HLA-DR (e), and on frozen sections for CD69 (d) and ICOS (f). Original magnification: ×100.

References

    1. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565–568.
    1. Loetscher P., Moser B., Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol. 2000;74:127–180.
    1. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000;52:145–176.
    1. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000;18:593–620.
    1. Zlotnik A., Yoshie O. Chemokinesa new classification system and their role in immunity. Immunity. 2000;12:121–127.
    1. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science. 1999;286:2098–2102.
    1. Campbell J.J., Butcher E.C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 2000;12:336–341.
    1. Melchers F., Rolink A.G., Schaniel C. The role of chemokines in regulating cell migration during humoral immune responses. Cell. 1999;99:351–354.
    1. Nakano H., Mori S., Yonekawa H., Nariuchi H., Matsuzawa A., Kakiuchi T. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood. 1998;91:2886–2895.
    1. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999;189:451–460.
    1. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., Cyster J.G. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 1999;189:403–412.
    1. Vassileva G., Soto H., Zlotnik A., Nakano H., Kakiuchi T., Hedrick J.A., Lira S.A. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 1999;190:1183–1188.
    1. Förster R., Schubel A., Breitfeld D., Kremmer E., Renner-Müller I., Wolf E., Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23–33.
    1. Legler D.F., Loetscher M., Roos R.S., Clark-Lewis I., Baggiolini M., Moser B. B cell–attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 1998;187:655–660.
    1. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 1998;391:799–803.
    1. Bowman E.P., Campbell J.J., Soler D., Dong Z., Manlongat N., Picarella D., Hardy R.R., Butcher E.C. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J. Exp. Med. 2000;191:1303–1318.
    1. Förster R., Mattis A.E., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87:1037–1047.
    1. Ansel K.M., Ngo V.N., Hyman P.L., Luther S.A., Forster R., Sedgwick J.D., Browning J.L., Lipp M., Cyster J.G. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406:309–314.
    1. Luther S.A., Lopez T., Bai W., Hanahan D., Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 2000;12:471–481.
    1. Voigt I., Camacho S.A., de Boer B.A., Lipp M., Forster R., Berek C. CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone. Eur. J. Immunol. 2000;30:560–567.
    1. Cyster J.G., Ngo V.N., Ekland E.H., Gunn M.D., Sedgwick J.D., Ansel K.M. Chemokines and B-cell homing to follicles. Curr. Top. Microbiol. Immunol. 1999;246:87–93.
    1. Ansel K.M., McHeyzer-Williams L.J., Ngo V.N., McHeyzer-Williams M.G., Cyster J.G. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 1999;190:1123–1134.
    1. Mazzucchelli L., Blaser A., Kappeler A., Schärli P., Laissue J.A., Baggiolini M., Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 1999;104:R49–R54.
    1. Förster R., Emrich T., Kremmer E., Lipp M. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood. 1994;84:830–840.
    1. Loetscher P., Seitz M., Baggiolini M., Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 1996;184:569–577.
    1. Willimann K., Legler D.F., Loetscher M., Roos R.S., Delgado M.B., Clark-Lewis I., Baggiolini M., Moser B. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 1998;28:2025–2034.
    1. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 1994;269:232–237.
    1. Brandes M., Legler D.F., Sporri B., Schaerli P., Moser B. Activation-dependent modulation of B lymphocyte migration to chemokines. Int. Immunol. 2000;12:1285–1292.
    1. Sallusto F., Lenig D., Förster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–712.
    1. Warnock R.A., Campbell J.J., Dorf M.E., Matsuzawa A., McEvoy L.M., Butcher E.C. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J. Exp. Med. 2000;191:77–88.
    1. Stein J.V., Rot A., Luo Y., Narasimhaswamy M., Nakano H., Gunn M.D., Matsuzawa A., Quackenbush E.J., Dorf M.E., von Andrian U.H. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function–associated antigen 1–mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 2000;191:61–76.
    1. Bermejo M., Martin-Serrano J., Oberlin E., Pedraza M.A., Serrano A., Santiago B., Caruz A., Loetscher P., Baggiolini M., Arenzana-Seisdedos F., Alcami J. Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur. J. Immunol. 1998;28:3192–3204.
    1. Förster R., Kremmer E., Schubel A., Breitfeld D., Kleinschmidt A., Nerl C., Bernhardt G., Lipp M. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsetsrapid internalization and recycling upon activation. J. Immunol. 1998;160:1522–1531.
    1. Agace W.W., Amara A., Roberts A.I., Pablos J.L., Thelen S., Uguccioni M., Li X.Y., Marsal J., Arenzana-Seisdedos F., Delaunay T. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr. Biol. 2000;10:325–328.
    1. Picker L.J., Singh M.K., Zdraveski Z., Treer J.R., Waldrop S.L., Bergstresser P.R., Maino V.C. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 1995;86:1408–1419.
    1. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 1996;272:60–66.
    1. Campbell J.J., Hedrick J., Zlotnik A., Siani M.A., Thompson D.A., Butcher E.C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science. 1998;279:381–384.
    1. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA. 1998;95:258–263.
    1. Pachynski R.K., Wu S.W., Gunn M.D., Erle D.J. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin α4β7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. J. Immunol. 1998;161:952–956.
    1. Flynn S., Toellner K.M., Raykundalia C., Goodall M., Lane P. CD4 T cell cytokine differentiationthe B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 1998;188:297–304.
    1. Walker L.S.K., Gulbranson-Judge A., Flynn S., Brocker T., Raykundalia C., Goodall M., Förster R., Lipp M., Lane P. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5–positive CD4 cells and germinal centers. J. Exp. Med. 1999;190:1115–1122.
    1. Saeki H., Moore A.M., Brown M.J., Hwang S.T. Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999;162:2472–2475.
    1. Goodnow C.C., Cyster J.G. Lymphocyte homingthe scent of a follicle. Curr. Biol. 1997;7:R219–R222.
    1. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397:263–266.
    1. Swallow M.M., Wallin J.J., Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity. 1999;11:423–432.
    1. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 1999;402:827–832.
    1. Ling V., Wu P.W., Finnerty H.F., Bean K.M., Spaulding V., Fouser L.A., Leonard J.P., Hunter S.E., Zollner R., Thomas J.L. Cutting edgeidentification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 2000;164:1653–1657.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner